← NDC auxiliary source history
FDA Establishment Identifier 946499746
Every current compounder row and every parsed outsourcing-response revision row carrying this exact FEI. Repeated physical rows and parser-specific revisions remain visible.
Establishment names in FDA source rows#
| Exact source name |
|---|
| Hikma Pharmaceuticals USA Inc. |
Exact matches in existing FDA.report company datasets#
Company links appear only when an indexed FDA.report dataset contains the exact establishment name.
| Company | Matching dataset |
|---|---|
| Hikma Pharmaceuticals USA Inc. | NDC |
Current compounder rows#
| Current source record | Source row | Product NDC | Package NDC | Active ingredient | Establishment | Period | Source date | Normalization | Row hash |
|---|---|---|---|---|---|---|---|---|---|
outsourcing:2026-1:387 | 387 | 63037-101 | 63037-101-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2026-1 | 2026-11-14 | valid | 60d281df870e… |
outsourcing:2026-1:388 | 388 | 63037-100 | 63037-100-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2026-1 | 2026-11-14 | valid | 53e7a1fd1796… |
outsourcing:2026-1:790 | 790 | 63037-198 | 63037-198-01 | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | 2026-1 | 2026-11-14 | valid | 0f191eeec916… |
outsourcing:2025-2:378 | 378 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2025-2 | 2026-11-14 | valid | d69e41eb631e… |
outsourcing:2025-2:379 | 379 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2025-2 | 2026-11-14 | valid | c2db4e493bc3… |
outsourcing:2025-1:382 | 382 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2025-1 | 2026-11-14 | valid | d92a761c1a8e… |
outsourcing:2025-1:397 | 397 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2025-1 | 2026-11-14 | valid | dde5e4c6eb04… |
outsourcing:2024-2:437 | 437 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2024-2 | 2026-11-14 | valid | 289af58e3347… |
outsourcing:2024-2:438 | 438 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2024-2 | 2026-11-14 | valid | 775983367602… |
outsourcing:2024-1:421 | 421 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2024-1 | 2026-11-14 | valid | 5ee57b06f685… |
outsourcing:2024-1:422 | 422 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2024-1 | 2026-11-14 | valid | b48115627271… |
outsourcing:2023-2:449 | 449 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2023-2 | 2026-11-14 | valid | 2fc492834764… |
outsourcing:2023-2:450 | 450 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2023-2 | 2026-11-14 | valid | e87739ab2f74… |
outsourcing:2023-1:480 | 480 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2023-1 | 2026-11-14 | valid | 7f05b1c8749b… |
outsourcing:2023-1:481 | 481 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2023-1 | 2026-11-14 | valid | cff8c84eef0f… |
outsourcing:2022-2:397 | 397 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2022-2 | 2026-11-14 | valid | f18993f2f8ab… |
outsourcing:2022-2:398 | 398 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2022-2 | 2026-11-14 | valid | 3b23e1d6c20b… |
outsourcing:2022-1:473 | 473 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2022-1 | 2026-11-14 | valid | 1e19543c7acb… |
outsourcing:2022-1:474 | 474 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | 2022-1 | 2026-11-14 | valid | b6b99bff61a4… |
Parsed outsourcing-response revision rows#
These are physical source-row memberships from every distinct parsed response revision, not deduplicated current records.
| Parsed revision | Source JSON | Period | Source date | Product NDC | Package NDC | Active ingredient | Establishment | Parser | Row hash |
|---|---|---|---|---|---|---|---|---|---|
ce3ced9163b6… | 387 | 2026-1 | 2026-11-14 | 63037-101 | 63037-101-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 60d281df870e… |
ce3ced9163b6… | 388 | 2026-1 | 2026-11-14 | 63037-100 | 63037-100-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 53e7a1fd1796… |
ce3ced9163b6… | 790 | 2026-1 | 2026-11-14 | 63037-198 | 63037-198-01 | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0f191eeec916… |
a0f355c22ab8… | 378 | 2025-2 | 2026-11-14 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d69e41eb631e… |
a0f355c22ab8… | 379 | 2025-2 | 2026-11-14 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | c2db4e493bc3… |
e84b71a3d2be… | 382 | 2025-1 | 2026-11-14 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d92a761c1a8e… |
e84b71a3d2be… | 397 | 2025-1 | 2026-11-14 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | dde5e4c6eb04… |
b9251e57ff7d… | 437 | 2024-2 | 2026-11-14 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 289af58e3347… |
b9251e57ff7d… | 438 | 2024-2 | 2026-11-14 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 775983367602… |
7cda94142886… | 421 | 2024-1 | 2026-11-14 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 5ee57b06f685… |
7cda94142886… | 422 | 2024-1 | 2026-11-14 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b48115627271… |
4879825e96ad… | 449 | 2023-2 | 2026-11-14 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 2fc492834764… |
4879825e96ad… | 450 | 2023-2 | 2026-11-14 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | e87739ab2f74… |
183b7730d766… | 480 | 2023-1 | 2026-11-14 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 7f05b1c8749b… |
183b7730d766… | 481 | 2023-1 | 2026-11-14 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | cff8c84eef0f… |
6eec0ac95f99… | 397 | 2022-2 | 2026-11-14 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | f18993f2f8ab… |
6eec0ac95f99… | 398 | 2022-2 | 2026-11-14 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b23e1d6c20b… |
3bedd3faaaf2… | 473 | 2022-1 | 2026-11-14 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 1e19543c7acb… |
3bedd3faaaf2… | 474 | 2022-1 | 2026-11-14 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b6b99bff61a4… |
4e9b3bad06ad… | 387 | 2026-1 | 2026-11-12 | 63037-101 | 63037-101-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 60d281df870e… |
4e9b3bad06ad… | 388 | 2026-1 | 2026-11-12 | 63037-100 | 63037-100-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 53e7a1fd1796… |
4e9b3bad06ad… | 790 | 2026-1 | 2026-11-12 | 63037-198 | 63037-198-01 | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0f191eeec916… |
a1adc6aa8212… | 378 | 2025-2 | 2026-11-12 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d69e41eb631e… |
a1adc6aa8212… | 379 | 2025-2 | 2026-11-12 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | c2db4e493bc3… |
f940ee0e2d4a… | 382 | 2025-1 | 2026-11-12 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d92a761c1a8e… |
f940ee0e2d4a… | 397 | 2025-1 | 2026-11-12 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | dde5e4c6eb04… |
170a2039d539… | 437 | 2024-2 | 2026-11-12 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 289af58e3347… |
170a2039d539… | 438 | 2024-2 | 2026-11-12 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 775983367602… |
0a2f3fd9e986… | 421 | 2024-1 | 2026-11-12 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 5ee57b06f685… |
0a2f3fd9e986… | 422 | 2024-1 | 2026-11-12 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b48115627271… |
30134e6d2755… | 449 | 2023-2 | 2026-11-12 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 2fc492834764… |
30134e6d2755… | 450 | 2023-2 | 2026-11-12 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | e87739ab2f74… |
48a7af60185c… | 480 | 2023-1 | 2026-11-12 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 7f05b1c8749b… |
48a7af60185c… | 481 | 2023-1 | 2026-11-12 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | cff8c84eef0f… |
ff7ed77705bb… | 397 | 2022-2 | 2026-11-12 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | f18993f2f8ab… |
ff7ed77705bb… | 398 | 2022-2 | 2026-11-12 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b23e1d6c20b… |
075a6e481a45… | 473 | 2022-1 | 2026-11-12 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 1e19543c7acb… |
075a6e481a45… | 474 | 2022-1 | 2026-11-12 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b6b99bff61a4… |
49589bf5af4b… | 387 | 2026-1 | 2026-11-10 | 63037-101 | 63037-101-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 60d281df870e… |
49589bf5af4b… | 388 | 2026-1 | 2026-11-10 | 63037-100 | 63037-100-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 53e7a1fd1796… |
49589bf5af4b… | 790 | 2026-1 | 2026-11-10 | 63037-198 | 63037-198-01 | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0f191eeec916… |
19e51297a9cc… | 378 | 2025-2 | 2026-11-10 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d69e41eb631e… |
19e51297a9cc… | 379 | 2025-2 | 2026-11-10 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | c2db4e493bc3… |
c7f823a6e093… | 382 | 2025-1 | 2026-11-10 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d92a761c1a8e… |
c7f823a6e093… | 397 | 2025-1 | 2026-11-10 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | dde5e4c6eb04… |
04d567e6c6e6… | 437 | 2024-2 | 2026-11-10 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 289af58e3347… |
04d567e6c6e6… | 438 | 2024-2 | 2026-11-10 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 775983367602… |
fff4a8f9b9d3… | 421 | 2024-1 | 2026-11-10 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 5ee57b06f685… |
fff4a8f9b9d3… | 422 | 2024-1 | 2026-11-10 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b48115627271… |
e92da1139fe8… | 449 | 2023-2 | 2026-11-10 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 2fc492834764… |
e92da1139fe8… | 450 | 2023-2 | 2026-11-10 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | e87739ab2f74… |
b9b7e963f96c… | 480 | 2023-1 | 2026-11-10 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 7f05b1c8749b… |
b9b7e963f96c… | 481 | 2023-1 | 2026-11-10 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | cff8c84eef0f… |
5f5ce6394b23… | 397 | 2022-2 | 2026-11-10 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | f18993f2f8ab… |
5f5ce6394b23… | 398 | 2022-2 | 2026-11-10 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b23e1d6c20b… |
fecf7e983477… | 473 | 2022-1 | 2026-11-10 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 1e19543c7acb… |
fecf7e983477… | 474 | 2022-1 | 2026-11-10 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b6b99bff61a4… |
bc1c0749bbc0… | 387 | 2026-1 | 2026-11-08 | 63037-101 | 63037-101-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 60d281df870e… |
bc1c0749bbc0… | 388 | 2026-1 | 2026-11-08 | 63037-100 | 63037-100-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 53e7a1fd1796… |
bc1c0749bbc0… | 790 | 2026-1 | 2026-11-08 | 63037-198 | 63037-198-01 | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0f191eeec916… |
86d6aba062ce… | 378 | 2025-2 | 2026-11-08 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d69e41eb631e… |
86d6aba062ce… | 379 | 2025-2 | 2026-11-08 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | c2db4e493bc3… |
973820f7e8bf… | 382 | 2025-1 | 2026-11-08 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d92a761c1a8e… |
973820f7e8bf… | 397 | 2025-1 | 2026-11-08 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | dde5e4c6eb04… |
e438bdb75db0… | 437 | 2024-2 | 2026-11-08 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 289af58e3347… |
e438bdb75db0… | 438 | 2024-2 | 2026-11-08 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 775983367602… |
3a531b01872f… | 421 | 2024-1 | 2026-11-08 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 5ee57b06f685… |
3a531b01872f… | 422 | 2024-1 | 2026-11-08 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b48115627271… |
a04e3793c012… | 449 | 2023-2 | 2026-11-08 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 2fc492834764… |
a04e3793c012… | 450 | 2023-2 | 2026-11-08 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | e87739ab2f74… |
fd6a32bbc6d5… | 480 | 2023-1 | 2026-11-08 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 7f05b1c8749b… |
fd6a32bbc6d5… | 481 | 2023-1 | 2026-11-08 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | cff8c84eef0f… |
4a860d9f09a4… | 397 | 2022-2 | 2026-11-08 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | f18993f2f8ab… |
4a860d9f09a4… | 398 | 2022-2 | 2026-11-08 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b23e1d6c20b… |
8b411a74f154… | 473 | 2022-1 | 2026-11-08 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 1e19543c7acb… |
8b411a74f154… | 474 | 2022-1 | 2026-11-08 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b6b99bff61a4… |
9bc3acee5a5a… | 387 | 2026-1 | 2026-11-06 | 63037-101 | 63037-101-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 60d281df870e… |
9bc3acee5a5a… | 388 | 2026-1 | 2026-11-06 | 63037-100 | 63037-100-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 53e7a1fd1796… |
9bc3acee5a5a… | 790 | 2026-1 | 2026-11-06 | 63037-198 | 63037-198-01 | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0f191eeec916… |
109efb26b9e5… | 378 | 2025-2 | 2026-11-06 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d69e41eb631e… |
109efb26b9e5… | 379 | 2025-2 | 2026-11-06 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | c2db4e493bc3… |
9895610cdb99… | 382 | 2025-1 | 2026-11-06 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d92a761c1a8e… |
9895610cdb99… | 397 | 2025-1 | 2026-11-06 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | dde5e4c6eb04… |
a336954e10c5… | 437 | 2024-2 | 2026-11-06 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 289af58e3347… |
a336954e10c5… | 438 | 2024-2 | 2026-11-06 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 775983367602… |
e3bf6cb3c115… | 421 | 2024-1 | 2026-11-06 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 5ee57b06f685… |
e3bf6cb3c115… | 422 | 2024-1 | 2026-11-06 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b48115627271… |
92ac7e0f2883… | 449 | 2023-2 | 2026-11-06 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 2fc492834764… |
92ac7e0f2883… | 450 | 2023-2 | 2026-11-06 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | e87739ab2f74… |
b73564b91e03… | 480 | 2023-1 | 2026-11-06 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 7f05b1c8749b… |
b73564b91e03… | 481 | 2023-1 | 2026-11-06 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | cff8c84eef0f… |
7711d7f2b47c… | 397 | 2022-2 | 2026-11-06 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | f18993f2f8ab… |
7711d7f2b47c… | 398 | 2022-2 | 2026-11-06 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 3b23e1d6c20b… |
08c2eb6fce9f… | 473 | 2022-1 | 2026-11-06 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 1e19543c7acb… |
08c2eb6fce9f… | 474 | 2022-1 | 2026-11-06 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | b6b99bff61a4… |
9ec09a220edb… | 387 | 2026-1 | 2026-11-04 | 63037-101 | 63037-101-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 60d281df870e… |
9ec09a220edb… | 388 | 2026-1 | 2026-11-04 | 63037-100 | 63037-100-10 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 53e7a1fd1796… |
9ec09a220edb… | 790 | 2026-1 | 2026-11-04 | 63037-198 | 63037-198-01 | Morphine Sulfate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | 0f191eeec916… |
f89fec0b1fa9… | 378 | 2025-2 | 2026-11-04 | 63037-101 | 63037-101-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | d69e41eb631e… |
f89fec0b1fa9… | 379 | 2025-2 | 2026-11-04 | 63037-100 | 63037-100-05 | Fentanyl Citrate | Hikma Pharmaceuticals USA Inc. | ndc-aux-outsourcing-revision-2026-08-02-v1 | c2db4e493bc3… |